Banque Cantonale Vaudoise Has $31,000 Holdings in The Cooper Companies, Inc. $COO

Banque Cantonale Vaudoise cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 96.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 434 shares of the medical device company’s stock after selling 10,750 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Cooper Companies were worth $31,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in COO. JANA Partners Management LP purchased a new position in Cooper Companies during the 3rd quarter worth approximately $166,917,000. Alecta Tjanstepension Omsesidigt raised its stake in Cooper Companies by 15.8% during the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after purchasing an additional 213,500 shares during the period. DAVENPORT & Co LLC lifted its holdings in shares of Cooper Companies by 1,359.7% in the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after purchasing an additional 528,346 shares in the last quarter. Swiss Life Asset Management Ltd lifted its holdings in shares of Cooper Companies by 63.9% in the third quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after purchasing an additional 19,264 shares in the last quarter. Finally, Fluent Financial LLC acquired a new stake in shares of Cooper Companies in the fourth quarter worth $3,517,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of COO stock opened at $71.71 on Wednesday. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock’s 50-day moving average is $64.18 and its two-hundred day moving average is $73.50. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a market cap of $13.99 billion, a P/E ratio of 60.77, a PEG ratio of 1.87 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Citigroup restated a “neutral” rating and set a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Stifel Nicolaus lowered their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.